Production of interleukin-5 and the suppressive effect of cyclosporin A in childhood severe atopic dermatitis

Journal of Pediatrics

Volumn 128, Issue 1, 1996, Pages 152-155

  Ishii, E ^a   Yamamoto, S ^a   Sakai, R ^a   Hamasaki, Y ^a   Miyazaki, S ^a  

^a Saga Medical School   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5;

ARTICLE; ATOPIC DERMATITIS; CASE REPORT; CORTICOSTEROID THERAPY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TOPICAL DRUG ADMINISTRATION;

EID: 0030025677     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70449-3     Document Type: Article

References (16)

1. JM Sowden J Berth-Jones JS Ross Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis Lancet 338 1991 137 140
2. T Van Joost F Heule M Korstanje Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study Br J Dermatol 130 1994 634 640
3. B Guarneri L Califano SP Cannavo M Vaccaro Cyclosporin A treatment of severe atopic dermatitis in a child Pediatr Dermatol 11 1994 186
4. JM Hanifin G Raika Diagnostic features of atopic dermatitis Acta Dermatovenereol 92 suppl 92 1980 44 47
5. R Sorg J Enczmann U Sorg Rapid and sensitive mRNA phenotyping for interleukins (IL-1 to IL-6) and colony-stimulating factors (G-CSF, M-CSF, and GM-CSF) by reverse transcription and subsequent polymerase chain reaction Exp Hematol 19 1991 882 887
6. H Zachariae TS Olsen Efficacy of cyclosporin A (CyA) in psoriasis: an overview of dose/response, indications, concentrations and side-effects Clin Nephrol 43 1995 154 158
7. PF Hoyer G Offner K Wonigeit J Brodehl R Pichlmayr Dosage of cyclosporin A in children with renal transplants Clin Nephrol 22 1984 68 71
8. RDR Camp S Reitamo PS Friedmann V Ho F Heule Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993 Br J Dermatol 129 1993 217 220
9. KD Cooper Atopic dermatitis: recent trends in pathogenesis and therapy J Invest Dermatol 102 1994 128 137
10. H Enokihara H Kajitani S Nagashima Interleukin 5 activity in sera from patients with eosinophilia Br J Haematol 75 1990 458 462
11. Y Tanaka E Delaporte S Dubucquoi Interleukin-5 messenger RNA and immunoreactive protein expression by activated eosinophils in lesional atopic dermatitis skin J Invest Dermatol 103 1994 589 592
12. DZ Staynov TH Lee Expression of interleukin-5 and granulocyte-macrophage colony-stimulating factor in human peripheral blood mononuclear cells after activation with phorbol myristate acetate Immunology 75 1992 196 201
13. H Okayama T Fushimi S Shimura H Sasaki K Shirato Glucocorticoid suppressed production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjects J Allergy Clin Immunol 93 1994 1006 1012
14. FG Rolfe JM Hughes CL Armour WA Sewell Inhibition of interleukin-5 gene expression by dexamethasone Immunology 77 1992 494 499
15. A Mori M Suko Y Nishizaki Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid Int Arch Allergy Immunol 104 suppl 1 1994 32 35
16. A Haczku A Alexander P Brown The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma J Allergy Clin Immunol 93 1994 510 519